In last trading session, Oragenics Inc (AMEX:OGEN) saw 11.24 million shares changing hands with its beta currently measuring 0.44. Company’s recent per share price level of $0.32 trading at -$0.02 or -2.99% at ring of the bell on the day assigns it a market valuation of $3.97M. That closing price of OGEN’s stock is at a discount of -2318.75% from its 52-week high price of $7.74 and is indicating a premium of 21.88% from its 52-week low price of $0.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.29 million shares which gives us an average trading volume of 452.08K if we extend that period to 3-months.

Oragenics Inc (AMEX:OGEN) trade information

Upright in the red during last session for losing -2.99%, in the last five days OGEN remained trading in the red while hitting it’s week-highest on Tuesday, 12/17/24 when the stock touched $0.32 price level, adding 15.39% to its value on the day. Oragenics Inc’s shares saw a change of -94.22% in year-to-date performance and have moved -8.66% in past 5-day. Oragenics Inc (AMEX:OGEN) showed a performance of 12.07% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.43 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.34% during past 5 years.

Oragenics Inc (AMEX:OGEN)’s Major holders

Insiders are in possession of 25.41% of company’s total shares while institution are holding 11.13 percent of that, with stock having share float percentage of 14.92%. Investors also watch the number of corporate investors in a company very closely, which is 11.13% institutions for Oragenics Inc that are currently holding shares of the company.